ROBERT ROSEN

Profile

First Name

: ROBERT

Middle Name

:

Last Name

: ROSEN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
LINCOLN PEAK PARTNERS, INC.
STEVEN KELLEY, DAVID MONTANARO, KIRAN SHAH
DIRECTOR, EXECUTIVE OFFICER
KLS DIVERSIFIED FUND LP
STEPHEN CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, DONALD LAYTON, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT, MICHAEL ZARRILLI
DIRECTOR, EXECUTIVE OFFICER
KLS DIVERSIFIED FUND LTD.
STEPHEN CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, DONALD LAYTON, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT, MICHAEL ZARRILLI
DIRECTOR
AP PHARMA INC /DE/
MICHAEL A. ADAM, JOHN BARR, CRAIG COLLARD, STEPHEN R. DAVIS, SHARMILA DISSANAIKE, IRA DUARTE, PAUL GODDARD, CRAIG JOHNSON, KEVIN KOTLER, ADAM MORGAN, THOMAS OTTOBONI, RONALD PRENTKI, BARRY D. QUART, SUSAN RODRIGUEZ, TOBY ROSENBLATT, KEVIN TANG, KEVIN C. TANG, GREGORY TURNBULL, GREGORY C. TURNBULL, CHRISTIAN WAAGE, JOHN WHELAN, JOHN B. WHELAN, ROBERT ZERBE
DIRECTOR
ASEKO INC.
JOHN BENEKE, BRUCE BODE, ROBBY BOOTH, ROBERT BOOTH, DONALD M. CASEY, PATRICK CUA, DEBORAH DEAN, JOSEPH DIVER, ROBERT FISCHELL, SCOTT FISCHELL, TIM FISCHELL, TIM A. FISCHELL, JAY FLEISCHMAN, EDDIE FLOYD, EDWARD FLOYD, DANIEL FRANK, DANNY FRANK, PAUL FULCHINO, EDMOND FURLONG, SCOTT GOTTLIEB, SUE GRADY, RANDALL HAWKINS, RANDY HAWKINS, GREG HOWARD, GREGORY HOWARD, ROBERT LEONARD, BILL MATTHEWS, WILLIAM MATTHEWS, RAYMIE MCFARLAND, ANDREW MIDLER, MOLLY O-NEILL, CHERYL PEGUS, MEGAN PIETROPAOLO, CHARLIE DORN SMITH, LIONEL STERLING, TREFOR THOMAS, PHIL TORRENCE, PHILLIP TORRENCE, PHILLIP D. TORRENCE, LYNN VOGEL, STEPHEN WALLACK
EXECUTIVE OFFICER, DIRECTOR
KLS RATES FUND LP
STEPHEN CASPER, STEPHEN P. CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, DANIEL T. NAPOLI, ROBERT J. ROSEN, JOHN STEINHARDT
EXECUTIVE OFFICER, DIRECTOR
KLS RATES FUND LTD.
STEPHEN CASPER, STEPHEN P. CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, DANIEL T. NAPOLI, ROBERT J. ROSEN, JOHN STEINHARDT
EXECUTIVE OFFICER
KLS CREDIT OPPORTUNITIES FUND LP
STEPHEN CASPER, STEPHEN P. CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, DANIEL T. NAPOLI, ROBERT J. ROSEN, JOHN STEINHARDT
DIRECTOR
CONKWEST, INC.
RICHARD ADCOCK, MICHAEL BLASZYK, JOHN BRENNAN, WESLEY CLARK, CHERYL COHEN, RICHARD GOMBERG, STEVE GORLIN, STEVEN GORLIN, RONALD HERBERMAN, HENRY JI, HENRY JI, PH.D., HANS KLINGEMANN, HANS G. KLINGEMANN, HANS KLINGEMANN, M.D., PH.D., HANS KLINGERMANN, RICHARD KUSSEROW, LINDA MAXWELL, JOHN POTTS, JOHN T. POTTS, JR., M.D., DAVID SACHS, CHRISTOBEL SELECKY, BARRY SIMON, BARRY J SIMON, BARRY J. SIMON, M.D., PATRICK SOON-SHIONG, PATRICK SOON-SHIONG, M.D., JOHN THOMAS, JOHN C. THOMAS, JR.
DIRECTOR
NANTKWEST, INC.
RICHARD ADCOCK, MICHAEL BLASZYK, JOHN BRENNAN, WESLEY CLARK, CHERYL COHEN, RICHARD GOMBERG, STEVE GORLIN, STEVEN GORLIN, RONALD HERBERMAN, HENRY JI, HENRY JI, PH.D., HANS KLINGEMANN, HANS G. KLINGEMANN, HANS KLINGEMANN, M.D., PH.D., HANS KLINGERMANN, RICHARD KUSSEROW, LINDA MAXWELL, JOHN POTTS, JOHN T. POTTS, JR., M.D., DAVID SACHS, CHRISTOBEL SELECKY, BARRY SIMON, BARRY J SIMON, BARRY J. SIMON, M.D., PATRICK SOON-SHIONG, PATRICK SOON-SHIONG, M.D., JOHN THOMAS, JOHN C. THOMAS, JR.
EXECUTIVE OFFICER, DIRECTOR
KLS MACRO RATES FUND LP
STEPHEN CASPER, STEPHEN P. CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, DANIEL T. NAPOLI, ROBERT J. ROSEN, JOHN STEINHARDT
EXECUTIVE OFFICER, DIRECTOR
KLS MACRO RATES FUND LTD.
STEPHEN CASPER, STEPHEN P. CASPER, JEFFREY KRONTHAL, JEFFREY WILLIAM KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, DANIEL T. NAPOLI, ROBERT J. ROSEN, JOHN STEINHARDT
EXECUTIVE OFFICER
KLS SPECIAL SITUATIONS FUND A LP
STEPHEN CASPER, JEFFREY KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT
EXECUTIVE OFFICER
KLS SPECIAL SITUATIONS FUND B LP
STEPHEN CASPER, JEFFREY KRONTHAL, HARRY LENGSFIELD, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT
EXECUTIVE OFFICER
KLS STRUCTURED INCOME FUND A LP
STEPHEN CASPER, JEFFREY KRONTHAL, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT
EXECUTIVE OFFICER
KLS STRUCTURED INCOME FUND B LP
STEPHEN CASPER, JEFFREY KRONTHAL, HARRY WILLIAM LENGSFIELD, GARY LINFORD, DANIEL NAPOLI, JOHN STEINHARDT
EXECUTIVE OFFICER
CJIP IV CO-INVESTMENT, L.P.
JEREMY ANDERSON, N/A CARLYLE JAPAN IV, L.L.C., N/A CJIP IV CO-INVESTMENT GP, L.P., CHRISTOPHER FINN, KEVIN GASQUE, NORMA KUNTZ, RYAN TOTEJA
EXECUTIVE OFFICER
CJIP V CO-INVESTMENT, L.P.
SUSAN BASS, N/A CARLYLE JAPAN V, L.L.C., N/A CJIP V CO-INVESTMENT GP, L.P., CHRISTINA GIBBS, ANAT HOLTZMAN
EXECUTIVE OFFICER
ABINGWORTH BIOVENTURES 9 LP
N/A ABV 9 GP LP, N/A ABV 9 HOLDINGS, L.L.C., JEREMY ANDERSON, CHRISTINA GIBBS, DAVID LOBE, ELIZABETH MUSCARELLA, ROB ROSEN
EXECUTIVE OFFICER
ACCD 3 COINVESTMENT, L.P.
N/A ACCD 3 GP LP, N/A ACCD 3 HOLDINGS, L.L.C., JEREMY ANDERSON, CHRISTINA GIBBS, DAVID LOBE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-25
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2025-12-05 
2026-01-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2024-12-23 
2025-12-19
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-12-22 
2025-01-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2024-12-23 
2024-11-20
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
2023-11-17
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
2022-11-14
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
2021-11-12
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
2020-11-13
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-10-06 
2020-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2020-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2020-05-22
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-05-07 
2020-05-22
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2020-05-22
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2020-05-07 
2019-09-13
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2019-09-13
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2019-09-13
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2019-09-13
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2019-06-28
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-09 
2019-06-28
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-09 
2019-05-23
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2018-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2018-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2018-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2018-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2018-07-23
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-09 
2018-07-23
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2018-07-09 
2018-05-23
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2017-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2017-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2017-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2017-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2017-05-23
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2016-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2016-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2016-09-14
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2016-09-14
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2016-05-23
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2015-09-11
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2015-09-11
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2015-09-11
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2015-09-11
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2015-08-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-07-31 
2015-07-17
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
2015-06-24
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
2015-05-21
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2015-01-05
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-12-23 
2014-12-29
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2014-12-16 
2014-09-12
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2014-09-12
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2014-09-12
D/A
Link
HEDGE FUND 
 
 
 
2012-07-01 
2014-09-12
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2014-09-12
D/A
Link
HEDGE FUND 
 
 
 
2013-05-01 
2013-09-13
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2013-09-13
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2012-12-03
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2012-12-03
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2012-11-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-02 
2012-11-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-02 
2012-08-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-07-30 
2012-07-13
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-22 
2011-12-01
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2011-12-01
D/A
Link
HEDGE FUND 
 
 
 
2008-08-01 
2009-07-22
D
Link
OTHER TECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2009-07-14